HomeCompareBLAC vs EQR

BLAC vs EQR: Dividend Comparison 2026

BLAC yields 66.45% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLAC wins by $848.8K in total portfolio value
10 years
BLAC
BLAC
● Live price
66.45%
Share price
$3.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$889.2K
Annual income
$224,520.35
Full BLAC calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — BLAC vs EQR

📍 BLAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLACEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLAC + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLAC pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLAC
Annual income on $10K today (after 15% tax)
$5,647.84/yr
After 10yr DRIP, annual income (after tax)
$190,842.30/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, BLAC beats the other by $187,595.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLAC + EQR for your $10,000?

BLAC: 50%EQR: 50%
100% EQR50/50100% BLAC
Portfolio after 10yr
$464.8K
Annual income
$114,169.97/yr
Blended yield
24.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

BLAC
No analyst data
Altman Z
0.0
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLAC buys
0
EQR buys
0
No recent congressional trades found for BLAC or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLACEQR
Forward yield66.45%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$889.2K$40.5K
Annual income after 10y$224,520.35$3,819.61
Total dividends collected$751.0K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BLAC vs EQR ($10,000, DRIP)

YearBLAC PortfolioBLAC Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$17,345$6,644.52$11,248$547.57+$6.1KBLAC
2$29,329$10,770.65$12,701$666.53+$16.6KBLAC
3$48,404$17,021.48$14,405$814.59+$34.0KBLAC
4$78,046$26,253.78$16,413$999.84+$61.6KBLAC
5$123,071$39,562.00$18,795$1,232.92+$104.3KBLAC
6$189,990$58,304.31$21,639$1,527.95+$168.4KBLAC
7$287,408$84,118.67$25,057$1,903.80+$262.4KBLAC
8$426,453$118,925.90$29,197$2,385.87+$397.3KBLAC
9$621,221$164,916.57$34,250$3,008.70+$587.0KBLAC
10$889,227$224,520.35$40,467$3,819.61+$848.8KBLAC

BLAC vs EQR: Complete Analysis 2026

BLACStock

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Full BLAC Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this BLAC vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLAC vs SCHDBLAC vs JEPIBLAC vs OBLAC vs KOBLAC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.